LEADER 01399nam  2200445   450 
001 9910555183803321
005 20220923223624.0
010   $a1-119-55126-9
010   $a1-119-55125-0
010   $a1-119-55124-2
035   $a(MiAaPQ)EBC6881894
035   $a(Au-PeEL)EBL6881894
035   $a(CKB)21069156200041
035   $a(EXLCZ)9921069156200041
100   $a20220923d2022      uy             0
101 0 $aeng
135   $aurcnu||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aMutagenic impurities $estrategies for identification and control /$fedited by Andrew Teasdale
210  1$aHoboken, New Jersey :$cJohn Wiley & Sons, Incorporated,$d[2022]
210  4$dİ2022
215   $a1 online resource (547 pages)
311 08$aPrint version: Teasdale, Andrew Mutagenic Impurities Newark : John Wiley & Sons, Incorporated,c2022 9781119551218 
320   $aIncludes bibliographical references and index.
606   $aDrugs$xTesting
606   $aMutagenicity testing$vCongresses
608   $aElectronic books.
615  0$aDrugs$xTesting.
615  0$aMutagenicity testing
676   $a576.542
702   $aTeasdale$b Andrew
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910555183803321
996   $aMutagenic impurities$92917256
997   $aUNINA